Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Crosiers

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Neurobiology of Aging|February 17, 2012
Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian populationAline Verstraeten, Eline Wauters, David Crosiers, et al.
Neurobiology of Aging|November 29, 2011
DLB and PDD: a role for mutations in dementia and Parkinson disease genes?Bram Meeus, Aline Verstraeten, David Crosiers, et al.
Human Mutation|May 1, 2009
Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian populationKaren Nuytemans, Bram Meeus, David Crosiers, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2012
Guanosine triphosphate cyclohydrolase 1 promoter deletion causes dopa-responsive dystoniaJessie Theuns, David Crosiers, Luc Debaene, et al.
Neurology. Genetics|May 8, 2023
Exome Sequencing and Multigene Panel Testing in 1,411 Patients With Adult-Onset Neurologic DisordersNika Schuermans, Hannah Verdin, Jody Ghijsels, et al.
Acta Neuropathologica Communications|February 13, 2021
Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's diseaseStefanie Smolders, Stéphanie Philtjens, David Crosiers, et al.
Acta Neuropathologica|March 16, 2020
Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide exportShaun Martin, Stefanie Smolders, Chris Van den Haute, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|July 1, 2024
The Growing Role of Telerehabilitation and Teleassessment in the Management of Movement Disorders in Rare Neurological Diseases: A Scoping ReviewLuigi Lavorgna, Elisabetta Maida, Carola Reinhard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2014
Alpha-synuclein repeat variants and survival in Parkinson's diseaseSun Ju Chung, Joanna M Biernacka, Sebastian M Armasu, et al.
Journal of Neurology|March 21, 2023
COVID19-associated new-onset movement disorders: a follow-up studySusanne A Schneider, Soaham Desai, Onanong Phokaewvarangkul, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Neurobiology of Aging|February 17, 2012
Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian populationAline Verstraeten, Eline Wauters, David Crosiers, et al.
Neurobiology of Aging|November 29, 2011
DLB and PDD: a role for mutations in dementia and Parkinson disease genes?Bram Meeus, Aline Verstraeten, David Crosiers, et al.
Human Mutation|May 1, 2009
Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian populationKaren Nuytemans, Bram Meeus, David Crosiers, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2012
Guanosine triphosphate cyclohydrolase 1 promoter deletion causes dopa-responsive dystoniaJessie Theuns, David Crosiers, Luc Debaene, et al.
Neurology. Genetics|May 8, 2023
Exome Sequencing and Multigene Panel Testing in 1,411 Patients With Adult-Onset Neurologic DisordersNika Schuermans, Hannah Verdin, Jody Ghijsels, et al.
Acta Neuropathologica Communications|February 13, 2021
Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's diseaseStefanie Smolders, Stéphanie Philtjens, David Crosiers, et al.
Acta Neuropathologica|March 16, 2020
Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide exportShaun Martin, Stefanie Smolders, Chris Van den Haute, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|July 1, 2024
The Growing Role of Telerehabilitation and Teleassessment in the Management of Movement Disorders in Rare Neurological Diseases: A Scoping ReviewLuigi Lavorgna, Elisabetta Maida, Carola Reinhard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2014
Alpha-synuclein repeat variants and survival in Parkinson's diseaseSun Ju Chung, Joanna M Biernacka, Sebastian M Armasu, et al.
Journal of Neurology|March 21, 2023
COVID19-associated new-onset movement disorders: a follow-up studySusanne A Schneider, Soaham Desai, Onanong Phokaewvarangkul, et al.
Pageof 6